» Articles » PMID: 19350290

Cross-linking to an Interrupted Polypurine Sequence with a Platinum-modified Triplex-forming Oligonucleotide

Overview
Publisher Springer
Specialty Biochemistry
Date 2009 Apr 8
PMID 19350290
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Triplex-forming oligonucleotides (TFOs) can bind specifically to polypurine sequences in double-stranded DNA. A single interruption of this polypurine tract can greatly destabilize triplex formation. The stability of triplexes can be significantly enhanced by covalently linking the TFO to its DNA target with reactive functional groups conjugated to the TFO. Covalently cross-linked TFOs are effective inhibitors of transcription of the target DNA sequence. We have designed a TFO with a platinum-modified base that can interact with and cross-link to a cytosine interruption in the polypurine tract of a target DNA duplex. The TFO contains an N(4)-(aminoalkyl)cytosine derivatized with cis-diamminediaquaplatinum(II) or trans-diamminediaquaplatinum(II). When bound to its target, the tethered platinum of the TFO can reach across the major groove and form an adduct with the guanine N7 of the interrupting C.G base pair. The optimal tether length is five methylene groups, and cross-linking is most efficient when the tether is modified with trans-diamminediaquaplatinum(II). Cross-linking requires that the TFO is bound to its designated DNA target. Addition of cyanide to the cross-linked TFO product reversed the cross-link, behavior that is consistent with the presence of a platinum-guanine adduct. The kinetics of the cross-linking reaction were studied and the half-life of the cross-linking reaction was approximately 3 h. Our results demonstrate that platinum-conjugated TFOs can be designed to cross-link with DNA targets that contain a single pyrimidine interruption. Modifications of this type may prove useful for expanding the DNA sequences that can be targeted by TFOs and increasing the stability of the resulting triplexes.

Citing Articles

A Click Chemistry Approach to Targeted DNA Crosslinking with cis-Platinum(II)-Modified Triplex-Forming Oligonucleotides.

Hennessy J, McGorman B, Molphy Z, Farrell N, Singleton D, Brown T Angew Chem Int Ed Engl. 2021; 61(3):e202110455.

PMID: 34652881 PMC: 9299770. DOI: 10.1002/anie.202110455.


TTS mapping: integrative WEB tool for analysis of triplex formation target DNA sequences, G-quadruplets and non-protein coding regulatory DNA elements in the human genome.

Jenjaroenpun P, Kuznetsov V BMC Genomics. 2009; 10 Suppl 3:S9.

PMID: 19958507 PMC: 2788396. DOI: 10.1186/1471-2164-10-S3-S9.


Transplatin-conjugated triplex-forming oligonucleotides form adducts with both strands of DNA.

Campbell M, Miller P Bioconjug Chem. 2009; 20(12):2222-30.

PMID: 19950917 PMC: 2796241. DOI: 10.1021/bc900008s.

References
1.
Besch R, Marschall C, Schuh T, Giovannangeli C, Kammerbauer C, Degitz K . Triple helix-mediated inhibition of gene expression is increased by PUVA. J Invest Dermatol. 2004; 122(5):1114-20. DOI: 10.1111/j.0022-202X.2004.22521.x. View

2.
Vasquez K, Narayanan L, Glazer P . Specific mutations induced by triplex-forming oligonucleotides in mice. Science. 2000; 290(5491):530-3. DOI: 10.1126/science.290.5491.530. View

3.
Buchini S, Leumann C . Stable and selective recognition of three base pairs in the parallel triple-helical DNA binding motif. Angew Chem Int Ed Engl. 2004; 43(30):3925-8. DOI: 10.1002/anie.200460159. View

4.
Duval-Valentin G, Thuong N, Helene C . Specific inhibition of transcription by triple helix-forming oligonucleotides. Proc Natl Acad Sci U S A. 1992; 89(2):504-8. PMC: 48267. DOI: 10.1073/pnas.89.2.504. View

5.
Knauert M, Glazer P . Triplex forming oligonucleotides: sequence-specific tools for gene targeting. Hum Mol Genet. 2001; 10(20):2243-51. DOI: 10.1093/hmg/10.20.2243. View